(UTHR) United Therapeutics - Performance -10.9% in 12m
UTHR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
56.06%
#7 in Peer-Group
Rel. Strength
29.50%
#5236 in Stock-Universe
Total Return 12m
-10.89%
#69 in Peer-Group
Total Return 5y
136.97%
#9 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 11.3 |
| P/E Forward | 10.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 410.00 USD |
| 52 Week Low | 276.47 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 15.40 |
| Buy/Sell Signal +-5 | -0.41 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: UTHR (-10.9%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: UTHR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for UTHR
| Total Return (including Dividends) | UTHR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -11.27% | 3.18% | 4.52% |
| 3 Months | -7.79% | 2.36% | 10.25% |
| 12 Months | -10.89% | -10.75% | 14.16% |
| 5 Years | 136.97% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | UTHR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -60.8% | 30.9% | 79.1% |
| 3 Months | 3.4% | 63.2% | 91.7% |
| 12 Months | -44.9% | -83.8% | 44% |
| 5 Years | 90.9% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th22.00 | -14.00% | -15.11% |
| 3 Month | %th41.50 | -9.91% | -16.36% |
| 12 Month | %th66.00 | -0.16% | -21.95% |
| 5 Years | %th96.00 | 213.90% | 9.25% |
FAQs
Does United Therapeutics (UTHR) outperform the market?
No,
over the last 12 months UTHR made -10.89%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months UTHR made -7.79%, while XBI made 2.36%.
Performance Comparison UTHR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
UTHR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.2% | -15.8% | -25.7% | -25% |
| US NASDAQ 100 | QQQ | -3.8% | -16.8% | -27.1% | -25% |
| German DAX 40 | DAX | -4% | -11.6% | -40.9% | -42% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.5% | -13.8% | -21.7% | -28% |
| Hongkong Hang Seng | HSI | -3.5% | -18.1% | -42.8% | -47% |
| India NIFTY 50 | INDA | -3.6% | -13.6% | -26.6% | -11% |
| Brasil Bovespa | EWZ | -2.5% | -14.8% | -47.3% | -21% |
UTHR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.4% | -18.2% | -32% | -39% |
| Consumer Discretionary | XLY | -2.7% | -13.2% | -17.7% | -31% |
| Consumer Staples | XLP | 0.3% | -10% | -24.6% | -20% |
| Energy | XLE | 0.1% | -15.8% | -23% | -8% |
| Financial | XLF | -2.9% | -13.8% | -28.9% | -39% |
| Health Care | XLV | -2.1% | -12.9% | -19% | -5% |
| Industrial | XLI | -2.8% | -14.4% | -32.5% | -34% |
| Materials | XLB | -1.8% | -13.6% | -26.4% | -14% |
| Real Estate | XLRE | 1.5% | -10.8% | -24% | -23% |
| Technology | XLK | -4% | -19.7% | -27.8% | -22% |
| Utilities | XLU | -0.9% | -12.3% | -29.4% | -35% |
| Aerospace & Defense | XAR | -5.1% | -20.9% | -46.8% | -63% |
| Biotech | XBI | -1.6% | -14.5% | -12.9% | -0% |
| Homebuilder | XHB | -1.8% | -15.2% | -15.2% | -12% |
| Retail | XRT | -1% | -13.4% | -18.3% | -17% |
UTHR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.4% | -20.3% | -18.5% | -1% |
| Natural Gas | UNG | 1% | -14.7% | -12.3% | -11% |
| Gold | GLD | 2.4% | -9.8% | -45.7% | -51% |
| Silver | SLV | 0.3% | -18.9% | -43.9% | -32% |
| Copper | CPER | -4.1% | -19.9% | -44.1% | -26% |
UTHR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.5% | -13.1% | -21.8% | -12% |
| iShares High Yield Corp. Bond | HYG | -1.2% | -12.8% | -25.1% | -21% |